Zydus Lifesciences Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Total Qtr Revenue cr | 6,975.90 | 6,232.20 | 6,728.60 | 6,608.50 | 5,326.60 |
| Other Income Qtr Cr | 111.40 | 109.00 | 154.90 | 80.60 | 57.50 |
| Operating Revenues Qtr | 6,864.50 | 6,123.20 | 6,573.70 | 6,527.90 | 5,269.10 |
Loading chart... | |||||
Operating Expenses Qtr | 5,048.10 | 4,107.40 | 4,485.20 | 4,402.40 | 3,881.50 |
Operating Profit Qtr | 1,816.40 | 2,015.80 | 2,088.50 | 2,125.50 | 1,387.60 |
EBITDA Qtr Cr | 1,842.90 | 2,090.60 | 2,243.40 | 1,986.50 | 1,444.80 |
Depreciation Qtr | 359.60 | 301.90 | 238.10 | 237.90 | 229.00 |
Net Profit Qtr | 1,042.10 | 1,258.60 | 1,466.80 | 1,170.90 | 1,026.20 |
Basic EPS Qtr | 10.36 | 12.51 | 14.58 | 11.64 | 10.17 |
Open Demat Account